QA: Nascent Biotech Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001622057_2021_Nascent_Biotech_Inc.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001622057')"}

Graph

Absolute values for 0001622057, Nascent Biotech Inc.

  xvar xval
0 AssetsCurrent 3,218
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 2,878,922
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 320,930
9 ResearchAndDevelopmentExpense 293,709
10 remainder_Expenses 2,832,672
11 remainder_Revenues 0
12 remainder_NetIncome -556,848
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 3,218
1 Liabilities 2,878,922
2 Expenses 3,447,311
3 Revenues 0
4 StockholdersEquity -2,875,704
5 NetIncome -4,004,159
6 ComprehensiveNetIncome -4,004,159
7 BaseVar 3,443,150
8 EconomicCapitalRatio -6.21

Edgar->Model Mapping

Feature Distribution

Change over Time